“Growing Preference for Minimally Invasive and Targeted Therapies”
- A key trend in the North America Stents Market is the increasing preference for minimally invasive, targeted cardiovascular interventions, particularly percutaneous coronary intervention (PCI) using stents.
- Drug-eluting stents (DES) and bioresorbable vascular scaffolds (BVS) are gaining popularity due to their ability to reduce restenosis, enhance arterial healing, and provide targeted drug delivery directly at the lesion site.
- For instance, next-generation stents with biodegradable polymer coatings and tailored drug release profiles are offering greater flexibility and improved long-term outcomes, aligning with the growing demand for personalized treatment strategies
- The trend is further supported by advancements in stent delivery systems, enabling precise placement, reduced procedural time, and improved patient safety.
- Additionally, the integration of intravascular imaging technologies such as OCT (optical coherence tomography) and IVUS (intravascular ultrasound) enhances procedural accuracy, stent positioning, and clinical decision-making.
- This shift toward patient-centric, non-surgical cardiovascular solutions is reshaping interventional cardiology and driving innovation in the North America Stents Market .
